Center for Biotechnology :: About the Center

A new form of ultrasound that assesses multiple parameters of hard tissue like bone has been developed by Dr. Yi-Xian Qin of the Orthopaedic Director of the Orthopaedic Bioengineering Research Laboratory at Stony Brook University. This research may lead to early prediction of bone loss, a hallmark of osteoporosis, a disease affecting millions of Americans. Read full article here.

Michael R. Bielski, J.D., M.S. Assistant Director of Science & Technology Commercialization at the Center for Biotechnology reviewed "Commercializing Successful Biomedical Technologies: Basic Principles of the Development of Drugs, Diagnostics and Devices" by Shreefal S Mehta for Nature Biotechnoloy. Read full review here.

Director of Center for Biotechnology research featured on Discovery's Science Channel

The Research of Dr. Clinton Rubin, Director, Center for Biotechnology and Distinguished Professor and Chair, Biomedical Engineering at Stony Brook University and colleague Dr. Stefan Judex, Associate Professor of Biomedical Engineering was recently featured on the Science Channel. The episode of the channel's "Weird Connections" program was titled "Good Vibrations" and illustrated how the work of Dr's Rubin and Judex is being used not only to "grow stronger bones but also make less fat cell, but may be an aide in ending the obesity crisis".

Center for Biotechnology-Supported Technology Receives FDA Approval to Enter Clinical Trials for Cancer Therapy

September, 2008, Stony Brook, NY: Cornerstone Pharmaceuticals and the Center for Biotechnology, a New York State Center for Advanced Technology, recently announced receiving approval from the FDA to conduct a safety and early efficacy clinical trial of CPI-613, the first in class agent from its Altered Energy Metabolism Directed compound platform. The technology, developed by Drs. Paul Bingham and Zuzana Zachar of Stony Brook University, could potentially provide for a safer more effective chemotherapy for some of the most deadly cancers. Drs. Bingham and Zachar have been working with Cornerstone Pharmaceuticals, the exclusive licensee of the technology, to develop pharmaceutically acceptable analogues for cancer treatment of which CPI-613 is the lead product candidate.
The early-stage development of CPI-613 has been supported, in part, with funding provided by the Center for Biotechnology. Clinton Rubin, Ph.D., director of the Center for Biotechnology said “CPI-613 is an excellent example of how the partnership between industry, academia and government can accelerate the development of academic-based technologies that have the potential to significantly impact human health in a very positive way. This has truly been a collaborative effort and we are pleased to see CPI-613 begin clinical testing.”

For additional information regarding the Center for Biotechnology and it’s programs to support the growth of emerging companies in New York State, please contact Joseph Scaduto at the Center for Biotechnology at 631.632.8521.

Grants Available For Biotech Companies to Exhibit at BIO 2008

New York bioscience firms interested in exhibiting in the New York Pavilion at BIO 2008 for free are encouraged to enter the Innovation Competition. New York Loves Bio, in partnership with the New York Senate and NYSTAR, will award two scholarships for qualified expenses up to $10,000, making it possible for two life science firms to exhibit in the New York State Pavilion at BIO 2008.

Of Planning and Happenstance: A Career Primer
Presented by Dr. Robert Tillman, Director, Science Alliance for The New York Academy of Science
Wednesday, November 5, 2008 - 1:00pm
Center for Biotechnology - 3rd Floor Psychology A Building

"What do you want to do when you finish grad school?””What are you doing after your postdoc?” From parents to PI’s these are questions that you hear. So, what is your answer? Do you even have one?

Careers are like fingerprints, everyone (hopefully) has one but they are unique to the individual. The goals of this seminar are to provide a helping hand in understanding the nature of careers and giving you some tools to get a handle on your own path to success.

About Dr. Robert Tillman

Robert Tillman joined the Academy as Director of the Science Alliance in April 2008. In this role he facilitates a partnership of universities, teaching hospitals, and independent research facilities in the New York
City metro area and beyond in providing professional development and mentoring for students and postdocs in the sciences and engineering.

Bob received his Ph.D. in Immunology from Washington University in St. Louis, Missouri. After a two-year postdoctoral appointment at New York University School of Medicine, he entered the world of college
administration. In his position as Postdoctoral Program Coordinator at NYU School of Medicine he was involved in the continuing development of the school's postdoctoral program and collaboration with colleagues in area schools and organizations in the professional development of postdoctoral fellows in the New York Metropolitan area.

He is a member of the American Academy of Medical Colleges' (AAMC) Group on Graduate Research, Education, and Training Postdoctorate Leaders Section Steering Committee and has been active in various National Postdoctoral Association initiatives.

Fundamentals of the Bioscience Industry Program Information Sessions

How Will You Measure Up?
Find out how at the Fundamentals of the Bioscience Industry Program
Information Sessions

Whether you plan on continuing in academia or entering the industry workforce, understanding the bioscience industry is an edge you must have. The Center for Biotechnology’s Fundamentals of the Bioscience Industry Program can provide that edge. Attend the information session and meet the Fundamentals Program Alumni Network Executive Committee and Alumni and hear of the outstanding value and benefits of this industry-focused and industry-driven program. Discover new ways of thinking of your current research within the broader context of the dynamic bioscience industry.

New York City Information Session:
A Wine & Cheese Networking and Information Session Hosted by the Center for Biotechnology & Naturejobs,
the career portal of Nature Publishing Group.
Wednesday, September 10, 2008
6pm-8pm
Nature Publishing Group Offices - New York, NY
Register Here

Stony Brook University Information Session:
Wednesday, September 17, 2008
6pm-8pm
Center for Biotechnology – 3rd Floor Psychology A Building
Register Here

Attendance is free. Seating is on a first come, first served basis.
Please RSVP online for your preferred location

2008 Life Sciences Summit
Bridging the Gap
From Concept to Commercialization

Thursday, June 5, 2008
Hilton Long Island/Huntington
Melville, NY

Presented by the Center for Biotechnology & the Long Island Life Sciences Initiative (LILSI)

The Life Sciences Summit is designed to address issues of strategic importance to the life sciences industry and to generate new business opportunities. The event will feature three main tracks covering a diversity of issues related to New Business Opportunities, Innovation &Technology Development, and building a vibrant Workforce. More than 300 industry executives are expected to attend the program.

We are also pleased to bring back two special interest tracks for 2008; Human Resource Professionals developed by Opus Scientific, and Bioscience Professional Development. In addition, the 2008 Summit will host a life sciences Career Fair produced by Naturejobs.

NYBA 17th Annual Meeting
May 19-20, 2008
New York Marriott Marquis
Time Square, NY
Visit www.nyba.org for more information

New York Stem Cell Foundation 3rd annual public outreach panel on stem cell research - April 30

The New York Stem Cell Foundation is hosting their third annual public outreach panel on stem cell research entitled Stem Cell Research; Realizing the Promise on April 30th, 2008

Stem Cell Research: Realizing the Promise
Leading stem cell scientists and patient advocates give the full story on the latest developments in stem cell research. Excerpts from current films illustrate the promise of stem cell research in finding better treatments and cures. Participants include: Chuck Close, Kevin Eggan, PhD, Alexandra Reeve, Leonard Lopate, Brooke Ellison, Gerald Fischbach, MD, Jack Kessler, MD, and Susan L. Solomon.
April 30th, 2008
The TimesCenter
242 West 41st Street
6:30 p.m. - 8:00 p.m.
Visit the event website or click here for a PDF about the event.

Industrial and Technology Assistance Corporation (ITAC), in conjunction with NYCEDC, will host a Biotech R&D Funding Conference at Columbia University's Lerner Hall on March 18. The event will highlight R&D funding opportunities, including SBIR/STTR and QETC, as well as feature expert speakers, panels and one-on-one meetings with NIH Federal program managers. Columbia University Science and Technology Ventures and Fish & Richardson, P.C. are sponsors for this event.

Current News + Events